Stay updated with breaking news from Founded Entity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results demonstrate KarXT was not associated with clinically meaningful increases in blood pressure in adults with schizophrenia KarXT demonstrated a mean change from baseline to week 8 in 24-hour...
(RTTNews) - PureTech Health plc (PRTC, PRTC.L) noted that its Founded Entity, Karuna Therapeutics (KRTX), announced positive results from its Phas...
PureTech's Karuna receives positive results from its KarXT blood pressure trial
VE202 is an orally administered, rationally-defined bacterial consortium candidate for the treatment of ulcerative colitis Vedanta’s pipeline also includes VE303, its Phase 3 ready therapeutic...
Founded Entity Karuna Therapeutics submits New Drug Application to U.S. Food and Drug Administration for KarXT for the treatment of schizophrenia If approved, KarXT will be the first new mechanism...